These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. v-erbA cooperates with bFGF in neuroretina cell transformation. Garrido C; Li RP; Samarut J; Gospodarowicz D; Saule S Virology; 1993 Feb; 192(2):578-86. PubMed ID: 7678474 [TBL] [Abstract][Full Text] [Related]
3. EGF promotes in vivo tumorigenic growth of primary chicken embryo fibroblasts expressing v-myc and enhances in vitro transformation by the v-erbA oncogene. Khazaie K; Panayotou G; Aguzzi A; Samarut J; Gazzolo L; Jurdic P Oncogene; 1991 Jan; 6(1):21-8. PubMed ID: 1671532 [TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta 1-mediated growth inhibition in chick embryo fibroblasts: reversion by virally-expressed nuclear oncogenes. Piu F; Jurdic P; Brun G; Samarut J; Castellazzi M C R Acad Sci III; 1993 Aug; 316(8):772-9. PubMed ID: 8044700 [TBL] [Abstract][Full Text] [Related]
5. The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand-activated endogenous c-erbA and retinoic acid receptor. Schroeder C; Gibson L; Beug H Oncogene; 1992 Feb; 7(2):203-16. PubMed ID: 1347913 [TBL] [Abstract][Full Text] [Related]
6. Avian myeloblastic cell lines transformed by two nuclear oncoproteins, P135gag-myb-ets and p61/63myc: a model of retinoic acid-induced differentiation not abrogated by v-erbA. al Moustafa AE; Gautier R; Saule S; Dieterlen-Lièvre F; Cormier F Cell Growth Differ; 1994 Aug; 5(8):863-71. PubMed ID: 7986751 [TBL] [Abstract][Full Text] [Related]
7. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action. Schroeder C; Gibson L; Zenke M; Beug H Oncogene; 1992 Feb; 7(2):217-27. PubMed ID: 1347914 [TBL] [Abstract][Full Text] [Related]
8. The nuclear oncogenes v-erbA and v-ets cooperate in the induction of avian erythroleukemia. Metz T; Graf T Oncogene; 1992 Mar; 7(3):597-605. PubMed ID: 1347919 [TBL] [Abstract][Full Text] [Related]
9. A novel mechanism of action for v-ErbA: abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors. Desbois C; Aubert D; Legrand C; Pain B; Samarut J Cell; 1991 Nov; 67(4):731-40. PubMed ID: 1682056 [TBL] [Abstract][Full Text] [Related]
10. c-erbA alpha/T3R and RARs control commitment of hematopoietic self-renewing progenitor cells to apoptosis or differentiation and are antagonized by the v-erbA oncogene. Gandrillon O; Ferrand N; Michaille JJ; Roze L; Zile MH; Samarut J Oncogene; 1994 Mar; 9(3):749-58. PubMed ID: 7906409 [TBL] [Abstract][Full Text] [Related]
11. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant. Rapp UR; Troppmair J; Beck T; Birrer MJ Oncogene; 1994 Dec; 9(12):3493-8. PubMed ID: 7970709 [TBL] [Abstract][Full Text] [Related]
12. Mitogenesis of quiescent chick fibroblasts by v-Src: dependence on events at the membrane leading to early changes in AP-1. Catling AD; Wyke JA; Frame MC Oncogene; 1993 Jul; 8(7):1875-86. PubMed ID: 8510932 [TBL] [Abstract][Full Text] [Related]
13. Bicistronic retroviral vector reveals capacity of v-erbA to induce erythroleukemia and to co-operate with v-myb. Casini T; Graf T Oncogene; 1995 Sep; 11(6):1019-26. PubMed ID: 7566959 [TBL] [Abstract][Full Text] [Related]
14. V-erbA and c-erbA proteins enhance transcriptional activation by c-jun. Sharif M; Privalsky ML Oncogene; 1992 May; 7(5):953-60. PubMed ID: 1349165 [TBL] [Abstract][Full Text] [Related]
15. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter. Rascle A; Ghysdael J; Samarut J Oncogene; 1994 Oct; 9(10):2853-67. PubMed ID: 7916146 [TBL] [Abstract][Full Text] [Related]
16. v-erbA stimulates quail myoblast differentiation in a T3 independent, cell-specific manner. Cassar-Malek I; Marchal S; Altabef M; Wrutniak C; Samarut J; Cabello G Oncogene; 1994 Aug; 9(8):2197-206. PubMed ID: 7913543 [TBL] [Abstract][Full Text] [Related]
17. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation. Su ZZ; Yemul S; Stein CA; Fisher PB Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104 [TBL] [Abstract][Full Text] [Related]
18. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts. Basso J; Briggs J; Findlay C; Bos T Oncogene; 2000 Oct; 19(42):4876-85. PubMed ID: 11039905 [TBL] [Abstract][Full Text] [Related]